Skip to main content
Patients Referrer
 
Book Online Call Now Modify Booking
Image
Dr Shanalie Dias

Dr Shanalie
Dias

MBBS, FRANZCR
About

Dr Shanalie Dias is a radiologist and nuclear medicine trainee with a strong interest in molecular imaging and targeted therapies. She is based at our Southport and Redcliffe clinics.

Dr Shanalie graduated from the University of Queensland in 2017 with First Class Honours and was awarded the University Medal for academic excellence. Prior to commencing radiology training, she worked as a Principal House Officer in PET imaging at the Princess Alexandra Hospital, gaining valuable experience in advanced functional imaging.

During her radiology training, Dr Shanalie was awarded the prestigious C.E. Eddy Prize in 2021 for achieving the highest score in the Part 1 Radiology Examinations. She completed her radiology training and first year of nuclear medicine training at the Royal Brisbane and Women’s Hospital in 2026, where she developed significant expertise in targeted molecular therapies, including radioactive iodine and Lutetium (Lutate) therapy.

News & Articles

 

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Your Qscan Reports Are Now in My Health Record — Here's What It Means for You

Managing your health has always required juggling paperwork, referrals, test results, scan reports passed between spe

Radiology in Lung Cancer: Evolving roles in screening, staging, and restaging

Lung cancer remains the leading cause of cancer-related mortality globally.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.